Jan Bolinder

Professor

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jan Bolinder is a Professor at Karolinska Institutet in Sweden. His research focuses on diabetes management, particularly in adults with type 1 diabetes, encompassing areas such as continuous glucose monitoring and insulin therapy. Recent articles highlight the relationship between hypoglycaemia, cardiovascular risks, and the effectiveness of glucose management strategies in clinical settings.

Articles (6)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2020

Collaborators (4)

Neda Rajamand Ekberg

Karolinska Institutet

SWEDEN

View details

Sergiu Catrina

Karolinska University Hospital

SWEDEN

View details

Thomas Nyström

Karolinska Institutet

SWEDEN

View details

Magnus Löndahl

Department of Clinical Sciences, Lund University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jan Bolinder

Research Interests

Explore related searches

Contact this professor

About

Articles (6)

Severe hypoglycaemia is associated with increased risk of adverse cardiovascular complications in adults with type 1 diabetes: risk mitigation using intermittently scanned continuous glucose monitoring

Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Initiation of Intermittently Scanned Continuous Glucose Monitoring Is Associated With Reduced Hospitalization for Acute Diabetes Events and Cardiovascular Complications in Adults With Type 1 Diabetes

Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

New Insulins, Biosimilars, and Insulin Therapy.

Collaborators (4)

Neda Rajamand Ekberg

Sergiu Catrina

Thomas Nyström

Magnus Löndahl

Make your next move.